Concall Intelligence
Follow the Sept 2026 quarter results season by comparing what companies reported with what management said next. Search official call evidence, measurable guidance, changing outlook, operating risks, and prior commitments without treating commentary as a trading recommendation.
Management evidence
Generated 22 Oct, 10:33 pm IST · click a summary to inspect source-linked evidence for this results quarter.
| Company | Call and sources | Reported result | Management outlook | Evidence-led conclusion | Review |
|---|---|---|---|---|---|
| CREDITACC CREDITACCESS GRAMEEN LIMITED Financial Services · Small | Sept 2026 22 Oct 2026 Preliminary brief | Excellent 85/100 | Optimistic outlook No comparable prior call Guidance raised | CreditAccess Grameen Limited reported strong financial and operating performance for Q2 FY27, driven by robust AUM growth, improving asset quality back to pre-crisis levels, and higher profitability resulting in the highest-ever quarterly PAT crossing INR 500 Cr. Management revised FY27 performance guidance upwards across key return and margin metrics, supported by disciplined operating costs and strong capital positions. Evidence summary ready | |
| HSCL Himadri Speciality Chemical Limited Chemicals · Small | Sep 2026 22 Oct 2026 Preliminary brief | Good 62/100 | Optimistic outlook No comparable prior call No measurable guidance | Himadri Speciality Chemical Limited delivered robust consolidated revenue growth of 57.93% YoY to Rs. 1691.43 Cr and PAT growth of 31.33% YoY to Rs. 231.32 Cr for Q2 FY27, driven by scaling operations and value-added product expansion. However, significant working capital pressures resulted in negative net operating cash flows for H1 FY27. Evidence summary ready | |
| WELSPLSOL Welspun Specialty Solutions Limited IT · Small | Sept 2026 22 Oct 2026 Preliminary brief | Result pending No matching current-quarter result row | Cautious outlook No comparable prior call No measurable guidance | Welspun Specialty Solutions Limited reported a mixed Q2 FY27 performance characterized by flat YoY total income of INR 2,420 Mn and a sharp contraction in profitability metrics due to soaring raw material costs, freight disruptions, and EU import tariff pressures, though domestic bar sales volume showed resilience. Evidence summary ready | |
| IIFL IIFL Finance Limited Financial Services · Small | Sep 2026 22 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | IIFL Finance reported robust performance for Q2 FY27, with consolidated AUM reaching INR1,24,268 crores (up 38% YoY and 8% QoQ) and consolidated PAT crossing INR805 crores, up 13% QoQ and 93% YoY. The return on equity surpassed the 20% target at 20.1%, supported by steady asset quality (consolidated gross NPA improved by 7 bps QoQ to 1.48%), increased liquidity of INR13,805 crores, and stable capital adequacy of 23.5%. However, management faces challenges including capital-ra Evidence summary ready | |
| THELEELA Leela Palaces Hotels & Resorts Limited Consumer · Large | Sep 2026 22 Oct 2026 Transcript verified | Excellent 85/100 | Optimistic outlook No comparable prior call Guidance maintained | Leela Palaces Hotels & Resorts delivered exceptional performance in Q2 FY27 with 33% operating revenue growth and 36% EBITDA growth, supported by robust luxury demand, pricing power, and strong performance during marquee events like the BRICS summit in New Delhi. Evidence summary ready | |
| JINDALSAW Jindal Saw Limited Industrials · Large | Sept 2026 22 Oct 2026 Transcript verified | Bad 0/100 | Optimistic outlook No comparable prior call Guidance maintained | Jindal Saw delivered higher year-on-year revenues for Q2 FY27 but faced severe operational margin compression due to geopolitical tensions in West Asia delaying shipments, higher international/domestic logistics costs, soaring coking coal prices, and softness in the domestic water infrastructure segment. Evidence summary ready | |
| UJJIVANSFB Ujjivan Small Finance Bank Limited Financial Services · Micro | Sep 2026 22 Oct 2026 Transcript verified | Excellent 85/100 | Optimistic outlook No comparable prior call Guidance maintained | Ujjivan Small Finance Bank announced the early retirement of its MD & CEO due to health reasons and appointed Ms. Carol Furtado as Interim MD & CEO. Management reassured stakeholders of continuity in strategy, strong governance, and commitment to FY27 guidance, emphasizing that growth plans and capital adequacy remain unaffected by the leadership transition or potential delays in capital raising. The search for a permanent MD & CEO has been expedited. Evidence summary ready | |
| ELECON Elecon Engineering Company Limited Industrials · Large | Sept 2026 22 Oct 2026 Transcript verified | Good 55/100 | Optimistic outlook No comparable prior call Guidance maintained | Elecon delivered resilient H1 FY27 performance with 11% consolidated revenue growth and a stable EBITDA margin of 22.2%, supported by robust international momentum in gears and recovering project clearances in the MHE division despite near-term domestic softness and raw material volatility. Evidence summary ready | |
| JIOFIN Jio Financial Services Limited Financial Services · Large | Sep 2026 22 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | Jio Financial Services reported strong operational scale-up across its core verticals during Q2 FY27, backed by 154% YoY growth in Jio Credit AUM and significant digital user engagement, though consolidated reported PAT declined due to shifting dividend timing effects compared to the previous year. Evidence summary ready | |
| INDHOTEL The Indian Hotels Company Limited Consumer · Large | Sept 2026 21 Oct 2026 Preliminary brief | Average 52/100 | Optimistic outlook No comparable prior call Guidance raised | The Indian Hotels Company Limited reported strong financial results for Q2 FY27 with 21.7% YoY revenue growth and 19.4% YoY PAT growth, driven by robust domestic hospitality demand, scaling selective service brands, and asset management initiatives. Evidence summary ready | |
| 360ONE 360 ONE WAM LIMITED Financial Services · Mid | Sept 2026 21 Oct 2026 Transcript verified | Bad 0/100 | Cautious outlook No comparable prior call No measurable guidance | Quarterly results showed modest revenue growth and a decline in profit, while management highlighted strong AUM growth, improved ARR retention, and long‑term profitability targets, but flagged margin pressure from higher costs and reliance on UBS flow execution. Evidence summary ready | |
| WAAREERTL Waaree Renewable Technologies Limited Industrials · Micro | Sept 2026 21 Oct 2026 Preliminary brief | Bad 2/100 | Optimistic outlook No comparable prior call No measurable guidance | Waaree Renewable Technologies Limited reported strong top-line growth with Q2 FY27 revenue up 36.5% YoY to Rs 1,057.84 Cr, alongside a healthy unexecuted order book exceeding Rs 5,500 Cr. However, PAT contracted by 29.98% YoY to Rs 81.48 Cr due to higher input costs, employee expenses, and financing costs, leading to margin compression. Evidence summary ready | |
| E2E E2E Networks Limited IT · Small | Sept 2026 21 Oct 2026 Transcript verified | Good 55/100 | Optimistic outlook No comparable prior call No measurable guidance | E2E Networks delivered robust financial performance in Q2 FY27 with triple-digit YoY revenue growth and margin expansion, supported by Blackwell GPU deployment and improved utilization. Management maintains a disciplined approach to capex and avoids speculative guidance. Evidence summary ready | |
| ICICIPRULI ICICI Prudential Life Insurance Company Limited Financial Services · Large | Sep 2026 21 Oct 2026 Transcript verified | Good 65/100 | Optimistic outlook No comparable prior call No measurable guidance | ICICI Life delivered solid revenue and profit growth despite macro volatility, with strong VNB expansion and margin stability, while emphasizing continued investment in agency distribution and upcoming regulatory reforms. Evidence summary ready | |
| PIRAMALFIN Piramal Finance Limited Financial Services · Small | Sep 2026 19 Oct 2026 Preliminary brief | Excellent 77/100 | Optimistic outlook No comparable prior call Guidance maintained | Piramal Finance Limited reported strong financial results for Q1 FY27, driven by robust growth in retail lending and a granular Wholesale 2.0 portfolio, while successfully continuing the rundown of legacy wholesale assets. The company maintains solid capitalization, high liquidity coverage, and a steadily improving operating leverage. Evidence summary ready | |
| BAJFINANCE Bajaj Finance Limited Financial Services · Large | Sep 2026 19 Oct 2026 Preliminary brief | Excellent 75/100 | Optimistic outlook No comparable prior call Guidance maintained | Bajaj Finance Limited reported a strong performance for Q2 FY27 with a 26% YoY growth in AUM to ₹584,624 crore, supported by healthy profitability, improved asset quality metrics, and aggressive FINAI transformation initiatives, alongside a board-approved capital raising plan. Evidence summary ready | |
| INDIACEM The India Cements Limited Materials · Large | Sept 2026 19 Oct 2026 Preliminary brief | Excellent 80/100 | Optimistic outlook No comparable prior call No measurable guidance | The India Cements Limited delivered an improved operational and financial performance for Q2FY27, characterized by double-digit growth in domestic cement volume, higher operating EBITDA per ton, and a significant surge in profitability driven by operational efficiencies and capacity utilization, despite cost headwinds in fuel and power rates. Evidence summary ready | |
| ULTRACEMCO UltraTech Cement Limited Materials · Large | Sept 2026 19 Oct 2026 Preliminary brief | Average 52/100 | Optimistic outlook No comparable prior call No measurable guidance | UltraTech Cement reported solid year-on-year volume and earnings growth for Q2 FY27 driven by strong structural macro demand, although fuel and raw material cost inflation impacted sequential margins. Evidence summary ready | |
| UNIONBANK Union Bank of India Financial Services · Large | Sept 2026 19 Oct 2026 Preliminary brief | Good 70/100 | Optimistic outlook No comparable prior call No measurable guidance | Union Bank of India delivered solid financial performance for Q2 FY2027 with strong growth in Net Interest Income, improved asset quality metrics including lower GNPA and NNPA ratios, and robust capital adequacy, alongside ongoing investments in digital initiatives and centralized surveillance systems. Evidence summary ready | |
| GTPL GTPL Hathway Limited Media · Small | Sep 2026 19 Oct 2026 Transcript verified | Bad 2/100 | Cautious outlook No comparable prior call New guidance | GTPL delivered strong top‑line growth driven by subscriber additions and the ACT acquisition, but profitability remained weak with a negative PAT and a decline in operating EBITDA margin, highlighting the need for integration synergies and margin recovery. Evidence summary ready | |
| YESBANK Yes Bank Limited Financial Services · Mid | Sep 2026 19 Oct 2026 Preliminary brief | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | Yes Bank reported a Q2FY27 net profit of INR 1,080 crores, up 65% year-on-year, driven by healthy core operating income and steady asset quality, though the Supreme Court judgment on AT-1 bonds remains unrecognised pending assessment. Evidence summary ready | |
| METROPOLIS Metropolis Healthcare Limited Pharma · Micro | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | Metropolis Healthcare reported robust strategic positioning during its Investor and Analyst Meet, highlighting strong volume-led growth across B2C and B2B channels, expansion in tier-2/tier-3 towns, and margin expansion levers driven by specialty testing, genomics, and network productivity. Evidence summary ready | |
| POLICYBZR PB Fintech Limited Financial Services · Mid | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Cautious outlook No comparable prior call No measurable guidance | PB Fintech held an analyst and investor call addressing the draft regulatory proposals by the insurance regulator concerning commissions and distribution economics. Management stated that while life insurance NPV remains largely unaffected, general insurance (particularly retail health) faces a serious top-line compression of one-third to 40%. The company plans to absorb details, evaluate cost rationalization levers, and explore manufacturing and service monetization options. Evidence summary ready | |
| NOVARTIND Novartis India Limited Pharma · Small | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | Novartis India Limited is undergoing a complete commercial reset following its acquisition by ChrysCapital. The management aims to transition the company from a flattish revenue trajectory to a high-growth platform by building an internal field force of ~900 representatives, expanding distribution to 25 C&Fs and 4,000-5,000 distributors, executing strategic M&As (such as Minipress XL and ophthalmology in-licensing), and focusing on six core therapy areas. Evidence summary ready | |
| INDOBORAX Indo Borax & Chemicals Limited Industrials · Small | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | Indo Borax reported strong Q1 FY27 results with 31% operating revenue growth and a 59% jump in net profit, supported by robust execution and improved realizations. Management remains focused on operational efficiency, capacity utilization, and executing the acquisition of a majority stake in Kronox Lab Sciences. Evidence summary ready | |
| HTEL Hy-Tech Engineers Limited Industrials · Micro | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | Hy-Tech Engineers reported stable revenue of INR430 million in Q1 FY27, up 13% YoY, while margins saw mild pressure due to raw material price inflation before compensated revisions take effect. Management remains confident in steady long-term growth driven by capacity expansion from IPO proceeds, export penetration, and import substitution. Evidence summary ready | |
| INDIGOPNTS Indigo Paints Limited Consumer · Micro | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | Indigo Paints delivered a strong Q1 FY27 with 18.7% standalone revenue growth and a 42% jump in EBITDA, outperforming the broader paint sector despite initial raw material supply disruptions triggered by the Iran conflict. Evidence summary ready | |
| XTGLOBAL Xtglobal Infotech Limited IT · Small | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | Xtglobal Infotech reported steady operating performance for Q1 FY27 with modest revenue growth offset by a shift from onsite to offshore delivery, leading to margin expansion. Evidence summary ready | |
| SKYWAYS Skyways Air Services Limited Services · Micro | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | Skyways Air Services Limited reported a strong first earnings call for Q1 FY27, showcasing stellar revenue and operating EBITDA growth driven by robust air and ocean cargo volumes, alongside successful navigation of geopolitical crises like the West Asia conflict. However, yield improvements are largely tied to dynamic fuel index increases which act as a complete pass-through, and certain legal overhangs remain sub judice. Evidence summary ready | |
| ASTERDM Aster DM Healthcare Limited Pharma · Small | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | The successful merger and strong proforma FY2026 results, coupled with clear strategic priorities for integration and network expansion, suggest the company is on track to leverage scale and clinical depth. Management's focus on capital efficiency and margin improvement supports the long-term value creation thesis. Evidence summary ready | |
| HAPPSTMNDS Happiest Minds Technologies Limited IT · Micro | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | Happiest Minds Technologies announced a proposed combination with ITC Infotech involving a promoter stake sale by Mr. Soota and a subsequent scheme of amalgamation of Happiest Minds into ITC Infotech, aiming to accelerate the $1 billion revenue target to FY28. Evidence summary ready | |
| RACLGEAR RACL Geartech Limited IT · Small | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | RACL Geartech reported robust Q1 FY27 financial performance with consolidated revenue growing 22% YoY to Rs. 132.6 crores and EBITDA expanding 18% YoY to Rs. 32.2 crores, backed by strong execution in domestic markets and resilience in European exports, particularly KTM. Evidence summary ready | |
| PRASOLCHEM Prasol Chemicals Limited Chemicals · Micro | Oct 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | Prasol Chemicals reported an exceptional Q1 FY27 driven by strong underlying demand, higher realizations from lower-cost inventory in a rising price environment due to geopolitical supply-chain disruptions, and improved plant utilization, particularly at the Mahad facility which has turned EBITDA and PBT positive. Evidence summary ready | |
| UCOBANK UCO Bank Financial Services · Large | Oct 2026 19 Oct 2026 Transcript verified | Good 60/100 | Optimistic outlook No comparable prior call Guidance maintained | UCO Bank posted robust growth in advances and deposits, improved asset quality and stayed within most guidance, but faces margin pressure from hardened yields and a slight dip in CASA ratio. Evidence summary ready | |
| CRAMC Canara Robeco Asset Management Company Limited Financial Services · Micro | Oct 2026 19 Oct 2026 Transcript verified | Average 47/100 | Optimistic outlook No comparable prior call New guidance | Canara Robeco Asset Management Company (CRAMC) reported strong Q2 and H1 FY27 financial performance with double-digit YoY growth in revenue and PAT, despite significant market volatility and foreign portfolio outflows. Management highlighted the resilience of domestic investor participation and steady SIP flows as key industry drivers. The company plans to expand its product offerings with new NFOs and evaluate new business lines like passives, SIF, AIF, and GIFT City, while Evidence summary ready | |
| ICICIAMC ICICI Prudential Asset Management Company Limited Financial Services · Mid | Oct 2026 19 Oct 2026 Transcript verified | Average 42/100 | Neutral outlook No comparable prior call No measurable guidance | ICICI Prudential AMC reported a mixed quarter with strong AUM growth and operating profit, but PAT saw a QoQ degrowth primarily due to mark-to-market adjustments in other income. While the company maintained its market position and saw good traction in alternates and SIFs, systematic transaction flows moderated, and redemptions were slightly higher, particularly in hybrid schemes. Management remains focused on long-term growth, product diversification, and scaling existing al Evidence summary ready | |
| AXISBANK Axis Bank Limited Financial Services · Large | Sept 2026 17 Oct 2026 Preliminary brief | Good 70/100 | Optimistic outlook No comparable prior call No measurable guidance | Axis Bank delivered robust Q2FY27 performance with advances up 23% YoY and deposits up 21% YoY, while net profit grew 38% YoY to ₹7,003 crores supported by healthy net interest income growth and improving asset quality metrics. Evidence summary ready | |
| ICICIBANK ICICI Bank Limited Financial Services · Large | Sep 2026 17 Oct 2026 Preliminary brief | Good 70/100 | Optimistic outlook No comparable prior call No measurable guidance | ICICI Bank delivered robust performance in Q2-2027 with a 20.1% y-o-y increase in profit after tax to ₹ 148.43 bn, supported by strong loan growth across business banking and domestic corporate portfolios, further improvements in asset quality ratios, and healthy capital adequacy. Evidence summary ready | |
| URBANCO Urban Company Limited Consumer · Small | Sep 2026 17 Oct 2026 Transcript verified | Bad 22/100 | Optimistic outlook No comparable prior call Guidance maintained | Urban Company reported strong growth across its core businesses, with consolidated NTV up 39.1% YoY and revenue up 41.4% YoY. The core businesses (India Consumer Services, International, Native) are showing significant operating leverage and margin expansion, leading to a positive adjusted EBITDA of ₹30 crores excluding InstaHelp. However, consolidated results reflect a substantial ₹174 crore investment in InstaHelp, which remains a strategic focus for long-term market leader Evidence summary ready | |
| RBLBANK RBL Bank Limited Financial Services · Small | Sept 2026 16 Oct 2026 Preliminary brief | Excellent 85/100 | Optimistic outlook No comparable prior call No measurable guidance | RBL Bank reported a strong transformation following the completion of Emirates NBD's majority acquisition, resulting in massive capital expansion, superior credit ratings, and improving asset quality metrics in Q1 FY2027. Evidence summary ready | |
| LTF L&T Finance Limited Financial Services · Mid | Sept 2026 16 Oct 2026 Preliminary brief | Good 65/100 | Optimistic outlook No comparable prior call Guidance maintained | L&T Finance Limited (LTF) delivered strong financial performance for Q2FY27, characterized by 28% YoY book growth to Rs. 1,36,635 Cr, a 33% YoY increase in PAT to Rs. 975 Cr, and an expanding RoE of 13.56%. The company continues to advance its Lakshya 2031 strategy, anchored heavily by proprietary AI and deep tech platforms like Cyclops and Nostradamus, while maintaining robust asset quality and stable liability costs. Evidence summary ready | |
| ANANDRATHI Anand Rathi Wealth Limited Financial Services · Small | Sep 2026 16 Oct 2026 Transcript verified | Bad 2/100 | Optimistic outlook No comparable prior call Guidance maintained | Anand Rathi Wealth delivered a strong Q2 and H1 FY27, reporting consistent year-on-year growth in PAT and revenue, despite a challenging market environment. The company achieved record net flows and client acquisitions, maintaining low attrition rates. Management expressed optimism about future growth, reaffirming full-year guidance for revenue and PAT, and outlined strategic initiatives including the upcoming mutual fund license application and operationalization of GIFT Cit Evidence summary ready | |
| HDFCLIFE HDFC Life Insurance Company Limited Financial Services · Large | Sept 2026 15 Oct 2026 Preliminary brief | Average 35/100 | Optimistic outlook No comparable prior call Guidance maintained | HDFC Life delivered a resilient performance for H1 FY27, reporting steady growth in APE, Value of New Business (VNB), and Profit After Tax, supported by strong retail protection growth and a well-diversified distribution and product mix. Evidence summary ready | |
| SUDARSCHEM Sudarshan Chemical Industries Limited Chemicals · Micro | Sep 2026 10 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | Sudarshan Chemical delivered a robust Q1 FY2027 performance following the Clariant-Heubach integration, achieving consolidated revenue of over Rs.2,600 Crores and solid EBITDA expansion. Despite geopolitical headwinds and supply chain friction, management remains focused on value capture, cost reduction, and completing IT integration while maintaining a cautious wait-and-watch approach on guidance. Evidence summary ready | |
| COCHINSHIP Cochin Shipyard Limited Industrials · Mid | Sep 2026 10 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | Cochin Shipyard reported stable performance for Q1 FY27 with a turnover of INR 1,094.21 crores, PBT of INR 202.49 crores, and PAT of INR 151.45 crores. Management maintains a positive long-term growth outlook supported by a robust order book of INR 22,000 crores, expansion into ship repair and hybrid shipbuilding facilities, and strategic international partnerships despite execution dependencies and working capital pressures. Evidence summary ready | |
| WABAG VA Tech Wabag Limited Infra · Micro | Sept 2026 7 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | VA Tech Wabag reported record FY 2025-26 performance with revenue of INR 3,944 Crores, EBITDA of INR 524 Crores, and PAT of INR 371 Crores, supported by a robust order book exceeding INR 17,200 Crores and a net cash positive position for the sixth consecutive year. Evidence summary ready | |
| GRANULES Granules India Limited Pharma · Large | Sept 2026 6 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | Granules India Limited reported returning to growth in FY26 after three years of flat performance, backed by a strong net cash position following preferential warrants in September 2026. The company is executing a strategic transformation focusing on four growth engines (controlled substances, complex generics/early market opportunities, oncology, and peptide CDMO) while funding a 2,000 crore organic capex plan over the next 3 to 4 years. Evidence summary ready | |
| STEAMHOUSE Steamhouse India Limited Chemicals · Micro | Sept 2026 6 Oct 2026 Preliminary brief | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | Steamhouse India Limited delivered robust operational performance for Q1 FY27, driven by strong growth in steam volumes and operating leverage, while completing its strategic exit from low-margin coal trading effective April 1, 2026. Evidence summary ready | |
| ALLCARGO Allcargo Logistics Limited Services · Small | Sept 2026 3 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | Allcargo Logistics reported a purposeful transformation year in FY2025-26, integrating express distribution and contract logistics under Vision 2030, resulting in revenue of INR 2,058 crores and a 16% growth in EBITDA to INR 233 crores. Evidence summary ready |